← FDA Drug Approvals (Drugs@FDA)
FLOLAN
NDA · New Drug Application · Sponsor: GLAXOSMITHKLINE LLC · Approved 1995-09-20
Drug application
- FDA Application #
NDA020444- Application type
- New Drug Application
- Brand name
- FLOLAN
- Generic name
- EPOPROSTENOL SODIUM
- Active ingredients
- EPOPROSTENOL SODIUM
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Discontinued
- Sponsor
- GLAXOSMITHKLINE LLC
- Manufacturer
- GlaxoSmithKline LLC
- First approval
- 1995-09-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown